First design
Site Theme
A person’s chances of receiving a new diabetes diagnosis were 58 percent higher in the months following a COVID-19 infection than before infection, even in the omicron era, researchers reported Wednesday in the journal JAMA Network Open.
Equally concerning are the data on diabetes. In a systemic meta-analysis published in Scientific Reports last November, researchers collected data from 8 cohort studies involving more than 47 million people and found that COVID-19 infection was associated with a 66% higher risk of diabetes rise.
“Given the normal number of COVID-19 survivors worldwide, the modest increase in the threat of diabetes could correspond to a drastic increase in the number of others diagnosed with the disease worldwide,” wrote the authors, researchers at Penn State College.
In an observation written last year in The Lancet Diabetes
It’s still unclear how COVID-19 triggers such dramatic cardiometabolic in survivors, however, researchers have hypothesized that immune responses play a role. For example, in the case of diabetes, researchers hypothesized that inflammation due to COVID-19 contributes to insulin resistance.
In this week’s new study, researchers expanded knowledge to read about cardiometabolic links with COVID-19 through June 2022, an era that includes the wave of omicron coronavirus variants. Ask whether it poses less of an emotion threat in relation to long-term consequences, such as cardiovascular disease and diabetes. The answer, according to the study, is no.
The authors of the new study, researchers at Cedars Sinai Medical Center in Los Angeles, analyzed data from a cohort of more than 23,000 patients and calculated their chances of being diagnosed with diabetes in the 90 days before COVID-19 infection and 90 days after. an infection. To account for fewer doctor visits in certain aspects of the pandemic, the researchers adjusted data based on rates of diagnoses of non-COVID-related conditions, namely urinary tract infections and acid reflux.
In the adjusted model, the chances of being diagnosed with diabetes for the first time in the post-infection window were 58% higher compared to the chances before infection. And in other analyses, the threat remained in the rankings before and after the omicron era. Age and gender also did not seem to influence the threat.
Unvaccinated people gave the impression of having a higher risk of developing diabetes in the post-COVID window than vaccinated people, but the link was not statistically significant due to wide periods of confidence in probability estimates. Overall, the studies were combined in having an effect on the prestige of vaccination on the threat of long-term COVID-19-associated diseases, such as diabetes, given differences in definitions of prolonged COVID and in the time since vaccination. Some studies found no difference in threat, while others found that vaccination reduces the threat of long-term disease by up to 41%.
Overall, the researchers of the new diabetes study concluded that their data found a relationship between higher diabetes risks and COVID-19 infection, according to previous knowledge, and that “this risk persisted as the predominant omicron variant, and the relationship held even after controlling for temporary discoverers. “
Join the Ars Orbital Transmission email to get weekly updates to your inbox.